Application of thin-layer chromatographic data in quantitative structure-activity relationship assay of thiazole and benzothiazole derivatives with H1-antihistamine activity.: II

被引:17
作者
Brzezinska, E
Koska, G
Klimczak, A
机构
[1] Med Univ Lodz, Dept Analyt Chem, PL-90151 Lodz, Poland
[2] Med Univ Lodz, Dept Synth & Technol Drugs, PL-90151 Lodz, Poland
关键词
structure-activity relationships; lipophilicity; regression analysis; planar chromatography; thiazole; benzothiazoles; histamine; organosulfur compounds;
D O I
10.1016/S0021-9673(03)00961-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Quantitative structure-activity relationship (QSAR) analysis of H-1-antihistamine activity was carried out and chromatographic data of 2-[2-(phenylamino)thiazol-4-yl]ethanamine, 2-(2-benzyl-4-thiazolyl)ethanamine, 2-(2-benzhydrylthiazol-4-yl) ethylamine derivative, and 2-(1-piperazinyl- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives were obtained. Normal-phase (NP) TLC plates (silica gel 60F(254)), impregnated with solutions of selected amino acid mixtures. na solvents as human histamine H-1-receptor (hH1R) antagonistic (L-ASP. L-Asn. L-Thr and L-Lys) were used in two developing solvents as human histamine H-1-receptor (hH1R) antagonistic interaction models. The lipophilicity data of the examined compounds were obtained and used in the QSAR assay. Using regression analysis, relationships between chromatographic and biological activity data were found. The correlations obtained in the present experiment with NP-TLC are more significant that those obtained in the experiment with RP2 TLC, because of the optimal fitting of the chromatographic system conditions to the lipophilicity of solutes. All proposed chromatographic models should facilitate pre-selection of the new drug candidates. The correlations of calculated pA(2)(H-1) values of the tested compounds predicted by the use of the best equations versus their pA(2)(H-1) obtained from the biological tests were significant (R-2=0.91-0.94). (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 8 条
[1]   CHROMATOGRAPHIC BEHAVIOUR AND CHEMICAL STRUCTURE .1. SOME NATURALLY OCCURRING PHENOLIC SUBSTANCES [J].
BATESMITH, EC ;
WESTALL, RG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1950, 4 (04) :427-440
[2]   Application of thin-layer chromatographic data in quantitative structure-activity relationship assay of thiazole and benzothiazole derivatives with H1-antihistamine activity. I [J].
Brzezińska, Elzbieta ;
Kośka, Grazyna ;
Walczyński, Krzysztof .
Journal of Chromatography A, 2003, 1007 (1-2) :145-155
[3]   Histaprodifens:: Synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H1-receptor agonists [J].
Elz, S ;
Kramer, K ;
Pertz, HH ;
Detert, H ;
ter Laak, AM ;
Kühne, R ;
Schunack, W .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (06) :1071-1084
[4]   VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities [J].
Takizawa, T ;
Matsumoto, J ;
Tohma, T ;
Kanke, T ;
Wada, Y ;
Nagao, M ;
Inagaki, N ;
Nagai, H ;
Zhang, MQ ;
Timmerman, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 2001, 86 (01) :55-64
[5]   THE HISTAMINE H-1-RECEPTOR ANTAGONIST BINDING-SITE - A STEREOSELECTIVE PHARMACOPHORIC MODEL-BASED UPON (SEMI-)RIGID H-1-ANTAGONISTS AND INCLUDING A KNOWN INTERACTION SITE ON THE RECEPTOR [J].
TERLAAK, AM ;
VENHORST, J ;
DENKELDER, GMDO ;
TIMMERMAN, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3351-3360
[6]   Histamine H1 receptor ligands Part I.: Novel thiazol-4-ylethanamine derivatives:: synthesis and in vitro pharmacology [J].
Walczynski, K ;
Timmerman, H ;
Zuiderveld, OP ;
Zhang, MQ ;
Glinka, R .
FARMACO, 1999, 54 (08) :533-541
[7]   Histamine H1 receptor ligands Part II.: Synthesis and in vitro pharmacology of 2-[2-(phenylamino)thiazol-4-yl]ethanamine and 2-(2-benzhydrylthiazol-4-yl)ethanamine derivatives [J].
Walczynski, K ;
Guryn, R ;
Zuiderveld, OP ;
Zhang, MQ ;
Timmerman, H .
FARMACO, 2000, 55 (9-10) :569-574
[8]   Non-imidazole histamine H3 ligands.: Part I.: Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives as H3-antagonists with H1 blocking activities [J].
Walczynski, K ;
Guryn, R ;
Zuiderweld, OP ;
Timmerman, H .
FARMACO, 1999, 54 (10) :684-694